from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1583c/-

LFCtreatmentdescriptionclass of inhibitor

0.358

Amikacinug/mL Amikacintranslation

-0.281

Cap5-10ug/mL Capreomycintranslation

-0.008

Rox10-50 ug/mL Roxithromycintranslation

-0.261

SM2-5 ug/mL Streptomycintranslation

0.552

Tet5-10 ug/mL Tetracyclinetranslation

0.968

Rif0.2-5ug/mL Rifampicintranscription

0.444

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.444

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.773

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.247

CPZ10-50 ug/mL Chlorpromazinerespiration

1.116

Clofazimine10-13 ug/mL Clofaziminerespiration

0.279

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.022

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.630

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.708

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.263

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.288

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.695

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.580

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.366

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.764

KCN5-20 ug/mL Potassium cyaniderespiration

0.616

NaN30.2-2 mM Sodium aziderespiration

-0.843

Nigericin50 uM Nigericinrespiration

-0.042

TRC10-150 ug/mL Triclosanrespiration

1.435

TRZ10-25 ug/mL Thioridazinerespiration

1.275

Valinomycin0.5-10 uM Valinomycinrespiration

-0.272

ZnSO42 mM ZnSO4respiration

-0.382

menadione6-10 ug/mL Menadionerespiration

-0.221

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.938

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.476

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.344

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.440

NRP_1Non-replicating persistence stage 1dosRassociated

-0.672

Amp0.2mg/mL AmpicillincellWall

-0.188

Cephalexin20-100 ug/mL CephalexincellWall

-0.489

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.604

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.304

EMB10-20 ug/mL EthambutolcellWall

-0.228

Eta12-40 ug/mL EthionamidecellWall

-0.163

INH0.2-0.4 ug/mL IsoniazidcellWall

0.082

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.223

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.301

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.589

BZA0.12 mg/mL BenzamidearomaticAmides

-0.494

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.484

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.255

H2O24 mM hydrogen peroxideDNAdamaging

0.425

Levo10 ug/mL LevofloxacinDNAdamaging

-0.968

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.492

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.153

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.736

UVUV-irradiationDNAdamaging

1.400

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.005

Antimycin12.5-50 ug/mL Antimycin A?

-0.255

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.087

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.186

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.376

PA8240.2-2 ug/mL PA-824?

0.320

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.048

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.119

Verapamil50 uM Verapamil?

-0.400

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.060

methoxatin10-20 ug/mL Methoxatin?